Cardiac conduction block during secukinumab treatment.

His laboratory results were as follows: alanine aminotransferase at 120 U/L and aspartate aminotransferase at 72 U/L and hepatitis C viral RNA, 9.85 × 10 SP e6 sp IU/ml; a 24-dynamic electrocardiogram revealed a ventricular premature beat of nine times and complete right bundle branch block, and a color Doppler echocardiogram demonstrated a reduced compliance in the left ventricle and the ejection fraction was 65%. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. As for hepatitis C, the cardiovascular risk was lower after the hepatitis C virus RNA turned negative, which has been proved in some randomized clinical trials.2 Then, we focus on the drugs, including Zepatier and Secukinumab. [Extracted from the article]